By utilizing the CRISPR/CasΦ mechanism to edit tumor-associated genes in KCs, it was observed that specific clearance of KCs plays an important anti-tumor role in the early stage of liver metastasis, while dysfunction occurs in the later stage of liver metastasis. This evidence concerns the gene TBCE and neoplasm.